Lassa Fever in Post-Conflict Sierra Leone
Open Access
- 20 March 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Neglected Tropical Diseases
- Vol. 8 (3), e2748
- https://doi.org/10.1371/journal.pntd.0002748
Abstract
Lassa fever (LF), an often-fatal hemorrhagic disease caused by Lassa virus (LASV), is a major public health threat in West Africa. When the violent civil conflict in Sierra Leone (1991 to 2002) ended, an international consortium assisted in restoration of the LF program at Kenema Government Hospital (KGH) in an area with the world's highest incidence of the disease. Clinical and laboratory records of patients presenting to the KGH Lassa Ward in the post-conflict period were organized electronically. Recombinant antigen-based LF immunoassays were used to assess LASV antigenemia and LASV-specific antibodies in patients who met criteria for suspected LF. KGH has been reestablished as a center for LF treatment and research, with over 500 suspected cases now presenting yearly. Higher case fatality rates (CFRs) in LF patients were observed compared to studies conducted prior to the civil conflict. Different criteria for defining LF stages and differences in sensitivity of assays likely account for these differences. The highest incidence of LF in Sierra Leone was observed during the dry season. LF cases were observed in ten of Sierra Leone's thirteen districts, with numerous cases from outside the traditional endemic zone. Deaths in patients presenting with LASV antigenemia were skewed towards individuals less than 29 years of age. Women self-reporting as pregnant were significantly overrepresented among LASV antigenemic patients. The CFR of ribavirin-treated patients presenting early in acute infection was lower than in untreated subjects. Lassa fever remains a major public health threat in Sierra Leone. Outreach activities should expand because LF may be more widespread in Sierra Leone than previously recognized. Enhanced case finding to ensure rapid diagnosis and treatment is imperative to reduce mortality. Even with ribavirin treatment, there was a high rate of fatalities underscoring the need to develop more effective and/or supplemental treatments for LF. Lassa fever (LF) is a major public health threat in West Africa. After the violent civil conflict in Sierra Leone (1991 to 2002) ended, the LF research program at Kenema Government Hospital (KGH) was reestablished. Higher CFRs in LF patients were observed compared to studies conducted prior to the civil conflict. The criteria used for defining the stages of LF and differences in sensitivity of the assays used likely account for these differences. LF may be more widespread in Sierra Leone than recognized previously. Peak presentation of LF cases occurs in the dry season, which is consistent with previous studies. Our studies also confirmed reports conducted prior to the civil conflict that indicate that infants, children, young adults, and pregnant women are disproportionately impacted by LF. High fatality rates were observed among both ribavirin treated and untreated patients, which underscores then need for better LF treatments.Keywords
This publication has 34 references indexed in Scilit:
- A Historical Look at the First Reported Cases of Lassa Fever: IgG Antibodies 40 Years After Acute InfectionThe American Journal of Tropical Medicine and Hygiene, 2013
- Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infectionVirology Journal, 2011
- Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case reportVirology Journal, 2011
- Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case ReportVirology Journal, 2011
- Detection of Lassa Virus, MaliEmerging Infectious Diseases, 2010
- Improved Detection of Lassa Virus by Reverse Transcription-PCR Targeting the 5′ Region of S RNAJournal of Clinical Microbiology, 2010
- Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevanceVirology Journal, 2008
- New opportunities for field research on the pathogenesis and treatment of Lassa feverAntiviral Research, 2008
- Lassa FeverNew England Journal of Medicine, 1986
- Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra LeoneScience, 1974